Dr. Jennifer McVean, MD, stands at the forefront of pediatric diabetes care, blending her personal journey with Type 1 Diabetes and her professional expertise to transform treatment approaches for children and families worldwide.
Personal Journey Fuels Professional Passion
Diagnosed with Type 1 Diabetes at the age of 11, Dr. McVean’s firsthand experience with the condition has profoundly influenced her compassionate approach to patient care. This unique perspective drives her commitment to improving the lives of those affected by diabetes.
Academic and Professional Excellence
Dr. McVean earned her medical degree from the University of Minnesota Medical School, followed by a pediatric residency at the University of Colorado and a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. She is board-certified in both Pediatrics and Pediatric Endocrinology.
Throughout her career, Dr. McVean has held significant roles at esteemed institutions, including the University of Minnesota, Children’s Minnesota, and Gundersen Health System. Currently, she serves as the Senior Director of Medical Affairs for Medtronic Diabetes, where she leads initiatives to advance diabetes technology and patient outcomes.
Advancements in Diabetes Technology
Dr. McVean’s work has been instrumental in the development and implementation of automated insulin delivery systems. Notably, her research on the MiniMed™ 780G system demonstrated its effectiveness in improving overnight glycemic control and reducing the burden on patients, marking a significant advancement in diabetes management.
Commitment to Research and Advocacy
Beyond her clinical and technological contributions, Dr. McVean is deeply involved in research and advocacy. She has participated in studies examining the impact of tight glycemic control on pancreatic beta cell function in newly diagnosed pediatric Type 1 Diabetes patients, contributing valuable insights to the field.
Her active involvement with organizations such as the Juvenile Diabetes Research Foundation (JDRF) and the American Diabetes Association (ADA) underscores her dedication to advancing diabetes awareness, prevention, and treatment.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
For more information about Dr. Jennifer McVean and her contributions to pediatric diabetes care, visit her profile at Hudson Physicians.